Oxford Cancer Analytics Grabs £1.27M To Revolutonise Lung Cancer Management
Sep 06, 2021•almost 4 years ago
Amount Raised
£1.27 Million
Round Type
seed
Description
In the UK, it is reported that nearly 130 people are diagnosed with lung cancer every day. An early diagnosis will give a 57 per cent chance of survival for more than five years as compared to diagnosing at a later stage, wherein the survival rate is a meagre 3 per cent. This is where Oxcan (Oxford Cancer Analytics) comes to play as it strives to identify more cases in the early stage.